blood cell differentiation into neurons

NeuroKaire (formerly Genetika+) helps find the right antidepressant by understanding how each patient's unique brain and body responds to medication. The company transforms psychiatry and neurology by differentiating patients' blood cells into their neurons, using an AI-enabled paradigm for precision medicine in CNS diseases. Its BrightKaire test evaluates how antidepressant medications interact with an individual's brain biology before treatment begins, with testing conducted in CLIA certified, CAP accredited laboratories. NeuroKaire operates in the US

Read more

AI-enabled precision medicinebiological measurementbiological response assessmentcellular modelinglaboratory testing in CLIA certified, CAP accredited laboratories